Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19641325 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Use of Rosiglitazone in the Treatment of Endometriosis
Condition: Endometriosis
Intervention: Drug: Rosiglitazone

Indicates status has not been verified in more than two years